Erratum To: Prescribing Pattern and Resource Utilization of Monoamine Oxidase-B Inhibitors in Parkinson Treatment: Comparison Between Rasagiline and Selegiline

Neurological Sciences - Italy
doi 10.1007/s10072-016-2511-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Synthesis and Evaluation of Iodinated Benzamide Derivative as Selective and Reversible Monoamine Oxidase B Inhibitors.

Chemical and Pharmaceutical Bulletin
MedicineDrug DiscoveryChemistry
1992English

The Primary Structure of Bovine Monoamine Oxidase Type A. Comparison With Peptide Sequences of Bovine Monoamine Oxidase Type B and Other Flavoenzymes

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
1989English

Structure-Activity Relationship Analysis of 3-Phenylcoumarin-Based Monoamine Oxidase B Inhibitors

Frontiers in Chemistry
Chemistry
2018English

Design, Synthesis and Pharmacological Evaluation of New Coumarin Derivatives as Monoamine Oxidase a and B Inhibitors

2008English

Effects of Monoamine Oxidase Inhibitors on Cocaine Discrimination in Rats

Behavioural Pharmacology
PsychiatryMental HealthPharmacology
2006English

Controversies in Neurology: Why Monoamine Oxidase B Inhibitors Could Be a Good Choice for the Initial Treatment of Parkinson's Disease

BMC Neurology
MedicineNeurology
2011English

In Situ Monitoring of Dopamine Metabolism to Identify Improved Monoamine Oxidase (MAO) Inhibitors

Science-Business eXchange
2012English

The Role of Rasagiline in the Treatment of Parkinson’s Disease

Clinical Interventions in Aging
MedicineGerontologyGeriatrics
2010English

Changes in Intensity of Serotonin Syndrome Caused by Adverse Interaction Between Monoamine Oxidase Inhibitors and Serotonin Reuptake Blockers

Neuropsychopharmacology
PsychiatryMental HealthPharmacology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy